Trial Profile
Double-blind study of escitalopram in adult patients with major depressive disorder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Forest Laboratories
- 02 Mar 2012 Actual end date (Jul 2006) added as reported by ClinicalTrials.gov.
- 22 Dec 2007 Status change from in progress to completed
- 11 Oct 2005 New trial record.